ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,658 | +46.5% | 1,527 | +49.6% | 0.00% | – |
| Q1 2023 | $4,544 | -86.6% | 1,021 | -74.7% | 0.00% | – |
| Q4 2022 | $34,017 | +89.0% | 4,040 | +39.5% | 0.00% | – |
| Q3 2022 | $18,000 | +80.0% | 2,897 | +59.4% | 0.00% | – |
| Q1 2022 | $10,000 | +900.0% | 1,818 | +1128.4% | 0.00% | – |
| Q4 2021 | $1,000 | -75.0% | 148 | +261.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 41 | -30.5% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 59 | -6.3% | 0.00% | – |
| Q1 2021 | $7,000 | -22.2% | 63 | 0.0% | 0.00% | – |
| Q4 2020 | $9,000 | +125.0% | 63 | +23.5% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 51 | +18.6% | 0.00% | – |
| Q2 2020 | $3,000 | – | 43 | +330.0% | 0.00% | – |
| Q1 2020 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |